+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A computer-assisted EEG study on psychotropic properties of antiparkinsonian drugs



A computer-assisted EEG study on psychotropic properties of antiparkinsonian drugs



Seishin Shinkeigaku Zasshi 94(3): 238-262



For the purpose of determining psychotropic properties of antiparkinsonian substances, the author has carried out a quantitative analytic study on EEG changes induced by six marketed antiparkinsonian drugs in young normal volunteers. The drugs were six antiparkinsonian agents, l-dopa (LDP) 100 mg, trihexyphenidyl (THP) 2 mg, 4 mg, biperiden (BPD) 1 mg, 2 mg, 5 mg, mazaticol (MZC) 4 mg, 8 mg, amantadine (AMD) 100 mg, bromocriptine (BMC) 1.25 mg, 2.5 mg, and amitriptyline (ATP) 25 mg, haloperidol (HPD) 3 mg, diazepam (DZP) 3 mg, inert placebo (PLB) as active and inactive controls. They were orally given to six healthy male volunteers respectively with two weeks interval and pre-drug, one, three, six hour post-drug EEGs were recorded and analyzed using our computer system with the periodgram technique. Placebo-controlled differences between pre- and post-drug EEGs were statistically treated with the principal component analysis. THP, BPD and MZC produced a marked decrease of alpha frequency associated with increases of slow and fast activities. In addition, MZC induced a slight delirious state with visual and auditory hallucinations at 8 mg in five of six subjects. EEG profiles of these drugs appeared very close to those of thymoleptics but the clinical observations suggest some psychodysleptic property of MZC at a higher dose. LDP provoked a decrease of lower alpha frequency and an increase of lower fast activity that may suggest central stimulant or mood elevating effects. BMC and AMD induced a decrease of slow activity associated with increases of higher alpha activity and lower fast activity in EEG and suggested their vigilance enhancing effects. Based on the current experience, it would be appropriate to use six EEG bands classification (delta, theta, lower alpha, higher alpha, lower beta, higher beta) instead of the fundamental four bands (delta, theta, alpha and beta) in pharmaco-EEG, as far as multivariate analysis of psychotropic drug profile is concerned. It must be noted that the higher part of alpha frequency present a completely different response from the lower part to the centrally effective drugs. Furthermore, psychiatrists should be as prudent as possible when prescribing antiparkinsonian drugs for prevention and treatment of drug induced extrapyramidalism.

(PDF emailed within 1 workday: $29.90)

Accession: 039053628

Download citation: RISBibTeXText

PMID: 1589555


Related references

Recent progress in development of psychotropic drugs (3)--Antiparkinsonian agents applied in the treatment of Parkinson's disease or are under investigation for patients or model animals. Nihon Shinkei Seishin Yakurigaku Zasshi 16(4): 113-122, 1996

Computer assisted analysis of a large group of compounds with psychotropic activity vi. use of topological and substructural descriptors to recognize the type of psychotropic activity. Khimiko Farmatsevticheskii Zhurnal (6): 709-714, 1985

Computer assisted analysis of a large number of compounds possessing psychotropic activity 7. use of molecular descriptors to recognize the type of psychotropic activity. Khimiko Farmatsevticheskii Zhurnal 20(6): 705-710, 1986

Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: A double-blind study. Japanese Journal of Psychiatry & Neurology 46(3): 733-739, 1992

Computer analysis of the file of compounds having psychotropic activity 3. differentiation of different types of psychotropic activity on the basis of topological and some physicochemical properties of the molecules. Khimiko Farmatsevticheskii Zhurnal 15(11): 63-68, 1981

Computer Eeg Of Second And Third Generation Of Psychotropic Drugs. Clinical Neuropharmacology 7: S64-S65, 1984

Computer assignment of psychotropic drugs. American Journal of Psychiatry 130(5): 595-598, 1973

A strategy for measuring the therapeutic properties of new antiparkinsonian drugs, such as +PHNO, in patients with on-off fluctuations. Clinical Neuropharmacology 12(1): 37-45, 1989

Effects of psychotropic drugs on computer sleep prints in man. Cerletti, A (Editor) Excerpta Medica International Congress Series No 180 The Present Status Of Psychotropic Drugs Xi+ 572p Excerpta Medica Foundation: Amsterdam, Netherlands 211-227, 1969

Computer assisted analysis of psychotropic compounds 4. method for the maximal grouping of parameters. Khimiko Farmatsevticheskii Zhurnal 17(8): 951-956, 1983

Psychotropic drugs and inflammatory reaction (III): Effects of single and repeated administration of psychotropic drugs on the bentonite oedema of the rat paw. Activitas Nervosa Superior 27(1): 21-22, 1985

Clinician-computer interaction: automated review of psychotropic drugs. American Journal of Psychiatry 141(2): 267-270, 1984

Bioequivalency and pharmacodynamics of psychotropic drugs based on computer-analyzed EEG. Psychopharmacology Bulletin 12(4): 60-61, 1976

Studies on the mechanism of action of the antiparkinsonian drugs memantine and amantadine: no evidence for direct dopaminomimetic or antimuscarinic properties. Archives Internationales de Pharmacodynamie et de Therapie 320: 21-42, 1992

Current aspects of accidents due to psychotropic drugs: massive absorption of psychotropic drugs in adults. Annales de Medecine Interne 123(8): 795-800, 1972